Therapeutic Inhibition of the Complement System

This publication has 475 references indexed in Scilit:

• EXPRESSION OF SIALYL LEWISX IN RAT HEART WITH ISCHAEMIA/REPERFUSION AND REDUCTION OF MYOCARDIAL REPERFUSION INJURY BY A MONOCLONAL ANTIBODY AGAINST SIALYL LEWISX
  The Journal of Pathology, 1996
• Complement-Mediated Antiinflammatory Action of Extracts and Pure Secoiridoids Isolated from Fraxinus Species
  Phytotherapy Research, 1996
• Antigen‐based heteropolymers: a potential therapy for binding and clearing autoantibodies via erythrocyte cr1
  Arthritis & Rheumatism, 1995
• Complement Activation and Polymorphonuclear Neutrophil Leukocyte Elastase in Sepsis
  Archives of Surgery, 1992
• Characterization of complement‐fixing antibodies to peripheral nerve myelin in Guillain‐Barré syndrome
  Annals of Neurology, 1990
• The clinical significance of iC3b neoantigen expression in plasma from patients with systemic lupus erythematosus
  Arthritis & Rheumatism, 1989
• Increased levels of plasma anaphylatoxins in systemic lupus erythematosus predict flares of the disease and may elicit vascular injury in lupus cerebritis
  Arthritis & Rheumatism, 1988
• Complement activation during systemic lupus erythematosus: C3A and C5a anaphylatoxins circulate during exacerbations of disease
  Arthritis & Rheumatism, 1986
• Inhibition of alternative pathway factor D by factor B ‐related synthetic hexapeptides
  European Journal of Immunology, 1982
• The effect of a cobra venom factor on complement and adjuvant‐induced disease in rats
  Arthritis & Rheumatism, 1973